EMBOL··X, created in 1999 (United States), from 150 sister brands and 2279 competing brands. The EMBOL··X brand is owned by Edwards Lifesciences, a company listed in New York. EMBOL··X is part of the Medical Devices & Instruments activity sector.
Investment simulator :
Portfolio valuation
Edwards Lifesciences
(EMBOL··X)
over 5 years*
USD 143.80